Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BNR NYSE:HEI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBNRBurning Rock Biotech$3.94+2.1%$3.12$2.18▼$7.90$42.35M0.7523,445 shs4,452 shsHEIHeico$312.60-1.3%$295.13$216.68▼$328.64$43.42B1.08481,345 shs181,768 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBNRBurning Rock Biotech+4.05%+19.20%+27.48%+27.06%-30.25%HEIHeico-0.37%-0.48%+4.36%+26.99%+41.01%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBNRBurning Rock BiotechN/AN/AN/AN/AN/AN/AN/AN/AHEIHeico2.7556 of 5 stars2.31.03.30.02.80.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBNRBurning Rock Biotech 0.00N/AN/AN/AHEIHeico 2.62Moderate Buy$292.36-6.47% DownsideCurrent Analyst Ratings BreakdownLatest SY1, BNR, 1COV, and HEI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025HEIHeicoBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$320.00 ➝ $355.006/24/2025HEIHeicoStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy$352.006/4/2025HEIHeicoMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$270.00 ➝ $305.006/2/2025HEIHeicoBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $280.005/30/2025HEIHeicoWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$244.00 ➝ $278.005/29/2025HEIHeicoUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$264.00 ➝ $306.004/17/2025HEIHeicoTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$294.00 ➝ $277.004/15/2025HEIHeicoWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$244.00(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBNRBurning Rock Biotech$523.28M0.08N/AN/A$7.39 per share0.53HEIHeico$4.13B10.52$4.88 per share64.04$26.64 per share11.73Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBNRBurning Rock Biotech-$47.49M-$1.89N/A∞N/A-45.41%-38.33%-25.34%N/AHEIHeico$514.11M$4.2872.9265.813.9914.54%15.88%7.76%8/25/2025 (Estimated)Latest SY1, BNR, 1COV, and HEI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/6/2025Q1 2025BNRBurning Rock BiotechN/A-$0.17N/A-$0.17N/A$18.34 million5/27/2025Q2 2025HEIHeico$1.03$1.12+$0.09$1.12$1.06 billion$1.10 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBNRBurning Rock BiotechN/AN/AN/AN/AN/AHEIHeico$0.240.08%N/A5.61%17 YearsLatest SY1, BNR, 1COV, and HEI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/12/2025HEIHeicosemi-annual$0.120.1%7/1/20257/1/20257/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBNRBurning Rock BiotechN/A3.022.76HEIHeico0.563.431.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBNRBurning Rock Biotech30.03%HEIHeico27.12%Insider OwnershipCompanyInsider OwnershipBNRBurning Rock Biotech30.30%HEIHeico9.55%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBNRBurning Rock Biotech1,39010.76 million7.50 millionNot OptionableHEIHeico10,000139.10 million125.82 millionOptionableSY1, BNR, 1COV, and HEI HeadlinesRecent News About These CompaniesBrokerages Set Heico Corporation (NYSE:HEI) PT at $292.36July 9 at 3:02 AM | americanbankingnews.comHEICO Corporation (HEI): A Bull Case TheoryJuly 7 at 5:04 PM | insidermonkey.comHeico Corporation (HEI) Is Up 3.24% in One Week: What You Should KnowJuly 7 at 1:05 PM | zacks.comEULAV Asset Management Boosts Position in Heico Corporation (NYSE:HEI)July 7 at 8:06 AM | marketbeat.comHeico Corporation (NYSE:HEI) Receives Consensus Rating of "Moderate Buy" from BrokeragesJuly 6, 2025 | marketbeat.comHeico Corporation (NYSE:HEI) Given Average Rating of "Moderate Buy" by AnalystsJuly 6, 2025 | americanbankingnews.comHeico Corporation (NYSE:HEI) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 6, 2025 | marketbeat.comIs Heico (HEI) Outperforming Other Aerospace Stocks This Year?July 4, 2025 | zacks.comBank of America Issues Positive Forecast for Heico (NYSE:HEI) Stock PriceJuly 4, 2025 | americanbankingnews.comBank of America Forecasts Strong Price Appreciation for Heico (NYSE:HEI) StockJuly 3, 2025 | marketbeat.com5 Momentum Picks for Third-Quarter 2025 After a Stellar Second QuarterJuly 3, 2025 | zacks.com2 Top-Ranked Stocks Suited for Momentum InvestorsJune 30, 2025 | zacks.comHeico (NYSE:HEI) Reaches New 12-Month High - Should You Buy?June 30, 2025 | marketbeat.comAstronics vs. Heico: Which Aerospace Tech Stock Has More Lift in 2025?June 30, 2025 | zacks.comZacks Research Comments on Heico's Q2 Earnings (NYSE:HEI)June 30, 2025 | americanbankingnews.comZacks Research Weighs in on Heico's Q2 Earnings (NYSE:HEI)June 30, 2025 | marketbeat.comHeico Corporation (NYSE:HEI) Shares Sold by K.J. Harrison & Partners IncJune 29, 2025 | marketbeat.comArtemis Investment Management LLP Purchases Shares of 28,489 Heico Corporation (NYSE:HEI)June 28, 2025 | marketbeat.com875 Shares in Heico Corporation (NYSE:HEI) Acquired by KPP Advisory Services LLCJune 28, 2025 | marketbeat.comFY2025 Earnings Estimate for Heico Issued By Zacks ResearchJune 27, 2025 | marketbeat.comHeico (HEI) Up 7.6% Since Last Earnings Report: Can It Continue?June 26, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSY1, BNR, 1COV, and HEI Company DescriptionsBurning Rock Biotech NASDAQ:BNR$3.94 +0.08 (+2.07%) As of 12:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.Heico NYSE:HEI$312.60 -4.25 (-1.34%) As of 12:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.HEICO Corporation, through its subsidiaries, designs, manufactures, and sells aerospace, defense, and electronic related products and services in the United States and internationally. Its Flight Support Group segment provides jet engine and aircraft component replacement parts; thermal insulation blankets and parts; renewable/reusable insulation systems; and specialty components. This segment also distributes hydraulic, pneumatic, structural, interconnect, mechanical, and electro-mechanical components for the commercial, regional, and general aviation markets; and offers repair and overhaul services for jet engine and aircraft component parts, avionics, instruments, composites, and flight surfaces of commercial aircraft, as well as for avionics and navigation systems, and other instruments utilized on military aircraft. The company's Electronic Technologies Group segment provides electro-optical infrared simulation and test equipment; electro-optical laser products; electro-optical, microwave, and other power equipment; electromagnetic and radio frequency (RF) interference shielding and suppression filters; power conversion and interface; interconnection devices; and underwater locator beacons and emergency locator transmission beacons. This segment also offers traveling wave tube amplifiers and microwave power modules; memory products and specialty semiconductors; harsh environment connectivity products and custom molded cable assemblies; RF and microwave products; communications and electronic intercept receivers and tuners; self-sealing auxiliary fuel systems; active antenna systems and airborne antennas; nuclear radiation detectors; silicone products; power amplifiers; ceramic-to-metal feedthroughs and connectors; technical surveillance countermeasures equipment; RF receivers and sources; embedded computing solutions; test sockets and adapters; and radiation assurance services. The company was incorporated in 1957 and is headquartered in Hollywood, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Will Oracle's Cloud and AI Deals Propel It to New Highs? Enovix Shares Hit 6-Month High; Long-Term Highs to Follow Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Microsoft Keeps Showing Up in Congressional Portfolios Buffett's $2B+ Bet With Big Long-Term Potential Just Got Upgraded Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
